Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer

Karen Anderson, Sahar Sibani, Garrick Wallstrom, Eliseo A. Mendoza, Jacob Raphael, Eugenie Hainsworth, Wagner R. Montor, Jessica Wong, Jin Park, Naa Lokko, Tanya Logvinenko, Niroshan Ramachandran, Andrew K. Godwin, Jeffrey Marks, Paul Engstrom, Joshua LaBaer

Research output: Contribution to journalArticle

147 Citations (Scopus)

Abstract

Cancer patients spontaneously generate autoantibodies (AAb) to tumor-derived proteins. To detect AAb, we have probed novel high-density custom protein microarrays (NAPPA) expressing 4988 candidate tumor antigens with sera from patients with early stage breast cancer (IBC), and bound IgG was measured. We used a three-phase serial screening approach. First, a prescreen was performed to eliminate uninformative antigens. Sera from stage I-III IBC (n = 53) and healthy women (n = 53) were screened for AAb to all 4988 protein antigens. Antigens were selected if the 95th percentile of signal of cases and controls were significantly different (p < 0.05) and if the number of cases with signals above the 95th percentile of controls was significant (p < 0.05). These 761 antigens were screened using an independent set of IBC sera (n = 51) and sera from women with benign breast disease (BBD) (n = 39). From these, 119 antigens had a partial area under the ROC curve (p < 0.05), with sensitivities ranging from 9-40% at >91% specificity. Twenty-eight of these antigens were confirmed using an independent serum cohort (n = 51 cases/38 controls, p < 0.05). Using all 28 AAb, a classifier was identified with a sensitivity of 80.8% and a specificity of 61.6% (AUC = 0.756). These are potential biomarkers for the early detection of breast cancer.

Original languageEnglish (US)
Pages (from-to)85-96
Number of pages12
JournalJournal of Proteome Research
Volume10
Issue number1
DOIs
StatePublished - Jan 7 2011

Fingerprint

Protein Array Analysis
Biomarkers
Microarrays
Early Detection of Cancer
Autoantibodies
Breast Neoplasms
Antigens
Proteins
Serum
Neoplasm Antigens
Area Under Curve
Tumors
Neoplasms
Screening
Classifiers
Immunoglobulin G

Keywords

  • Autoantibodies
  • Biomarker
  • Breast cancer
  • Protein microarrays
  • Proteomics

ASJC Scopus subject areas

  • Biochemistry
  • Chemistry(all)

Cite this

Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer. / Anderson, Karen; Sibani, Sahar; Wallstrom, Garrick; Mendoza, Eliseo A.; Raphael, Jacob; Hainsworth, Eugenie; Montor, Wagner R.; Wong, Jessica; Park, Jin; Lokko, Naa; Logvinenko, Tanya; Ramachandran, Niroshan; Godwin, Andrew K.; Marks, Jeffrey; Engstrom, Paul; LaBaer, Joshua.

In: Journal of Proteome Research, Vol. 10, No. 1, 07.01.2011, p. 85-96.

Research output: Contribution to journalArticle

Anderson, K, Sibani, S, Wallstrom, G, Mendoza, EA, Raphael, J, Hainsworth, E, Montor, WR, Wong, J, Park, J, Lokko, N, Logvinenko, T, Ramachandran, N, Godwin, AK, Marks, J, Engstrom, P & LaBaer, J 2011, 'Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer', Journal of Proteome Research, vol. 10, no. 1, pp. 85-96. https://doi.org/10.1021/pr100686b
Anderson, Karen ; Sibani, Sahar ; Wallstrom, Garrick ; Mendoza, Eliseo A. ; Raphael, Jacob ; Hainsworth, Eugenie ; Montor, Wagner R. ; Wong, Jessica ; Park, Jin ; Lokko, Naa ; Logvinenko, Tanya ; Ramachandran, Niroshan ; Godwin, Andrew K. ; Marks, Jeffrey ; Engstrom, Paul ; LaBaer, Joshua. / Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer. In: Journal of Proteome Research. 2011 ; Vol. 10, No. 1. pp. 85-96.
@article{6abe4d31df76435c84abae24e6dfc396,
title = "Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer",
abstract = "Cancer patients spontaneously generate autoantibodies (AAb) to tumor-derived proteins. To detect AAb, we have probed novel high-density custom protein microarrays (NAPPA) expressing 4988 candidate tumor antigens with sera from patients with early stage breast cancer (IBC), and bound IgG was measured. We used a three-phase serial screening approach. First, a prescreen was performed to eliminate uninformative antigens. Sera from stage I-III IBC (n = 53) and healthy women (n = 53) were screened for AAb to all 4988 protein antigens. Antigens were selected if the 95th percentile of signal of cases and controls were significantly different (p < 0.05) and if the number of cases with signals above the 95th percentile of controls was significant (p < 0.05). These 761 antigens were screened using an independent set of IBC sera (n = 51) and sera from women with benign breast disease (BBD) (n = 39). From these, 119 antigens had a partial area under the ROC curve (p < 0.05), with sensitivities ranging from 9-40{\%} at >91{\%} specificity. Twenty-eight of these antigens were confirmed using an independent serum cohort (n = 51 cases/38 controls, p < 0.05). Using all 28 AAb, a classifier was identified with a sensitivity of 80.8{\%} and a specificity of 61.6{\%} (AUC = 0.756). These are potential biomarkers for the early detection of breast cancer.",
keywords = "Autoantibodies, Biomarker, Breast cancer, Protein microarrays, Proteomics",
author = "Karen Anderson and Sahar Sibani and Garrick Wallstrom and Mendoza, {Eliseo A.} and Jacob Raphael and Eugenie Hainsworth and Montor, {Wagner R.} and Jessica Wong and Jin Park and Naa Lokko and Tanya Logvinenko and Niroshan Ramachandran and Godwin, {Andrew K.} and Jeffrey Marks and Paul Engstrom and Joshua LaBaer",
year = "2011",
month = "1",
day = "7",
doi = "10.1021/pr100686b",
language = "English (US)",
volume = "10",
pages = "85--96",
journal = "Journal of Proteome Research",
issn = "1535-3893",
publisher = "American Chemical Society",
number = "1",

}

TY - JOUR

T1 - Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer

AU - Anderson, Karen

AU - Sibani, Sahar

AU - Wallstrom, Garrick

AU - Mendoza, Eliseo A.

AU - Raphael, Jacob

AU - Hainsworth, Eugenie

AU - Montor, Wagner R.

AU - Wong, Jessica

AU - Park, Jin

AU - Lokko, Naa

AU - Logvinenko, Tanya

AU - Ramachandran, Niroshan

AU - Godwin, Andrew K.

AU - Marks, Jeffrey

AU - Engstrom, Paul

AU - LaBaer, Joshua

PY - 2011/1/7

Y1 - 2011/1/7

N2 - Cancer patients spontaneously generate autoantibodies (AAb) to tumor-derived proteins. To detect AAb, we have probed novel high-density custom protein microarrays (NAPPA) expressing 4988 candidate tumor antigens with sera from patients with early stage breast cancer (IBC), and bound IgG was measured. We used a three-phase serial screening approach. First, a prescreen was performed to eliminate uninformative antigens. Sera from stage I-III IBC (n = 53) and healthy women (n = 53) were screened for AAb to all 4988 protein antigens. Antigens were selected if the 95th percentile of signal of cases and controls were significantly different (p < 0.05) and if the number of cases with signals above the 95th percentile of controls was significant (p < 0.05). These 761 antigens were screened using an independent set of IBC sera (n = 51) and sera from women with benign breast disease (BBD) (n = 39). From these, 119 antigens had a partial area under the ROC curve (p < 0.05), with sensitivities ranging from 9-40% at >91% specificity. Twenty-eight of these antigens were confirmed using an independent serum cohort (n = 51 cases/38 controls, p < 0.05). Using all 28 AAb, a classifier was identified with a sensitivity of 80.8% and a specificity of 61.6% (AUC = 0.756). These are potential biomarkers for the early detection of breast cancer.

AB - Cancer patients spontaneously generate autoantibodies (AAb) to tumor-derived proteins. To detect AAb, we have probed novel high-density custom protein microarrays (NAPPA) expressing 4988 candidate tumor antigens with sera from patients with early stage breast cancer (IBC), and bound IgG was measured. We used a three-phase serial screening approach. First, a prescreen was performed to eliminate uninformative antigens. Sera from stage I-III IBC (n = 53) and healthy women (n = 53) were screened for AAb to all 4988 protein antigens. Antigens were selected if the 95th percentile of signal of cases and controls were significantly different (p < 0.05) and if the number of cases with signals above the 95th percentile of controls was significant (p < 0.05). These 761 antigens were screened using an independent set of IBC sera (n = 51) and sera from women with benign breast disease (BBD) (n = 39). From these, 119 antigens had a partial area under the ROC curve (p < 0.05), with sensitivities ranging from 9-40% at >91% specificity. Twenty-eight of these antigens were confirmed using an independent serum cohort (n = 51 cases/38 controls, p < 0.05). Using all 28 AAb, a classifier was identified with a sensitivity of 80.8% and a specificity of 61.6% (AUC = 0.756). These are potential biomarkers for the early detection of breast cancer.

KW - Autoantibodies

KW - Biomarker

KW - Breast cancer

KW - Protein microarrays

KW - Proteomics

UR - http://www.scopus.com/inward/record.url?scp=79951521146&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951521146&partnerID=8YFLogxK

U2 - 10.1021/pr100686b

DO - 10.1021/pr100686b

M3 - Article

VL - 10

SP - 85

EP - 96

JO - Journal of Proteome Research

JF - Journal of Proteome Research

SN - 1535-3893

IS - 1

ER -